Evaluation of Efficacy of Lycium Barbarum Polysaccharide in Patients With Major Depressive Disorder
Evaluation of Efficacy of Lycium Barbarum Polysaccharide in Patients With Major Depressive Disorder: a Randomized,Placebo-controled Trial
Sponsor: Fifth Affiliated Hospital of Guangzhou Medical University
Listed as NCT04124276, this NA trial focuses on Depression and Depressive Disorder and remains ongoing. Sponsored by Fifth Affiliated Hospital of Guangzhou Medical University, it has been updated 7 times since 2019, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status NA
-
Nov 2022 — Mar 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fifth Affiliated Hospital of Guangzhou Medical University
- Guangzhou Psychiatric Hospital
For direct contact, visit the study record on ClinicalTrials.gov .